$OPBK
OP Bancorp Stock $opbk

$opbk Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038620 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue		$575.0K
YoY Change		26.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$361.0K	$308.0K
YoY Change	4.03%	-11.75%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense		$13.87M
YoY Change		380.03%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$7.297M	$7.020M
YoY Change	-34.36%	-42.29%
Income Tax	$2.125M	$1.900M
% Of Pretax Income	29.12%	27.07%
Net Earnings	$5.075M	$5.121M
YoY Change	-35.4%	-40.8%
Net Earnings / Revenue		890.61%
Basic Earnings Per Share		$0.33
Diluted Earnings Per Share	$0.34	$0.33
COMMON SHARES
Basic Shares Outstanding	15.00M shares	15.13M shares
Diluted Shares Outstanding		15.14M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$91.22M	$105.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$13.75M	$5.378M
YoY Change	212.39%	22.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.31M	$15.10M
YoY Change	-7.03%	-12.7%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.148B	$2.143B
YoY Change	2.54%	5.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.63M	$13.60M
YoY Change	355.72%	1137.49%
Accrued Expenses	$9.341M	$9.900M
YoY Change	-8.54%	4.38%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$21.97M	$23.50M
YoY Change	69.2%	122.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$20.58M	$14.70M
YoY Change	9.59%	-33.44%
Total Long-Term Liabilities	$20.58M	$14.70M
YoY Change	9.59%	-33.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.97M	$23.50M
Total Long-Term Liabilities	$20.58M	$14.70M
Total Liabilities	$1.955B	$1.958B
YoY Change	1.96%	5.32%
SHAREHOLDERS EQUITY
Retained Earnings	$120.9M	$117.5M
YoY Change	14.35%	18.09%
Common Stock	$87.22M	$88.24M
YoY Change	-2.07%	0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$192.6M	$184.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.148B	$2.143B
YoY Change	2.54%	5.57%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$5.075M	$5.121M
YoY Change	-35.4%	-40.8%
Depreciation, Depletion And Amortization	$361.0K	$308.0K
YoY Change	4.03%	-11.75%
Cash From Operating Activities	-$1.333M	$15.43M
YoY Change	-144.81%	-66.57%
INVESTING ACTIVITIES
Capital Expenditures	$231.0K	$580.0K
YoY Change	-36.54%	-341.67%
Acquisitions
YoY Change
Other Investing Activities	-$2.195M	-$36.72M
YoY Change	-97.41%	-76.27%
Cash From Investing Activities	-$2.426M	-$37.32M
YoY Change	-97.14%	-75.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.77M	-16.13M
YoY Change	-118.66%	-119.33%
NET CHANGE
Cash From Operating Activities	-1.333M	15.43M
Cash From Investing Activities	-2.426M	-37.32M
Cash From Financing Activities	-10.77M	-16.13M
Net Change In Cash	-14.52M	-38.02M
YoY Change	-40.25%	49.59%
FREE CASH FLOW
Cash From Operating Activities	-$1.333M	$15.43M
Capital Expenditures	$231.0K	$580.0K
Free Cash Flow	-$1.564M	$14.85M
YoY Change	-159.9%	-67.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	440000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	5121000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14999203	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82972000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	209809000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	12098000	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	44335000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1659051000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4400000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	7180000	usd
CY2022Q4	us-gaap	Servicing Asset ServicingAsset	12759000	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	21613000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	14316000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8993000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	20184000	usd
CY2023Q3	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	605509000	usd
CY2023Q3	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	348869000	usd
CY2023Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	420162000	usd
CY2023Q3	us-gaap	Deposits Deposits	1825171000	usd
CY2023Q3	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	95000000	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	13552000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	77632000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	10606000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	117483000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21414000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	184307000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2142675000	usd
CY2023Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	28250000	usd
CY2023Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1417000	usd
CY2023Q3	opbk	Loan Servicing Fees Net Of Amortization LoanServicingFeesNetOfAmortization	468000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1179000	usd
CY2023Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther	379000	usd
CY2023Q3	us-gaap	Noninterest Income NoninterestIncome	2601000	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7014000	usd
CY2023Q3	us-gaap	Occupancy Net OccupancyNet	1706000	usd
CY2023Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	773000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1899000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-5069000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-23285000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-1362000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-2780000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-1498000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-6884000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3246000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	961000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	858000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	753000	usd
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	5847000	usd
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	10601000	usd
	opbk	Bank Owned Life Insurance Income Expense BankOwnedLifeInsuranceIncomeExpense	458000	usd
	opbk	Bank Owned Life Insurance Income Expense BankOwnedLifeInsuranceIncomeExpense	330000	usd
	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-106000	usd
	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-438000	usd
	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	64362000	usd
	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	86033000	usd
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	112070000	usd
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	161287000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	816000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1072000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2929000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	11068000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10781000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	541000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4200000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-229000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	69175000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	80759000	usd
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	57247000	usd
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	127999000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	18887000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	26194000	usd
	us-gaap	Payments For Proceeds From Life Insurance Policies PaymentsForProceedsFromLifeInsurancePolicies	0	usd
	opbk	Payments To Acquire Loans And Servicing Rights PaymentsToAcquireLoansAndServicingRights	21916000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1953000	usd
	opbk	Payments For Proceeds From Investment In Low Income Housing Partnerships PaymentsForProceedsFromInvestmentInLowIncomeHousingPartnerships	1563000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-73546000	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-60600000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	888000	usd
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	95000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2582000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5469000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4851000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	98000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	79000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	287879000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001722010
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#InterestReceivable
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#InterestReceivable
CY2023Q3	us-gaap	Assets Assets	2142675000	usd
CY2023Q3	opbk	Interest Bearing Deposit Other Time Deposit InterestBearingDepositOtherTimeDeposit	450631000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	9926000	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	14719000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1958368000	usd
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15149203	shares
CY2023Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	31186000	usd
CY2023Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	13006000	usd
CY2023Q3	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	867000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	13873000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	2890000	usd
	us-gaap	Interest Expense InterestExpense	37425000	usd
	us-gaap	Interest Expense InterestExpense	4613000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17313000	usd
CY2023Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1359000	usd
CY2023Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	15954000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	575000	usd
CY2023Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	369000	usd
CY2023Q3	opbk	Noninterest Expense Foundation Donation And Other Contributions NoninterestExpenseFoundationDonationAndOtherContributions	529000	usd
CY2023Q3	us-gaap	Noninterest Expense NoninterestExpense	11535000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7020000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	5121000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-4608000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-9404000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1875000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	183770000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	5121000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3246000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	154000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18746000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3571000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	790000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	961000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	298484	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2582000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2582000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.36
	us-gaap	Dividends Cash DividendsCash	5469000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	184307000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	165222000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
	us-gaap	Dividends Cash DividendsCash	4851000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	170095000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18746000	usd
	us-gaap	Net Income Loss NetIncomeLoss	25282000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1021000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1999000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	975000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1020000	usd
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	187000	usd
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	546000	usd
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	3302000	usd
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	3512000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2199000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3972000	usd
	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	1084000	usd
	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	584000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2003000	usd
	us-gaap	Payments For Proceeds From Life Insurance Policies PaymentsForProceedsFromLifeInsurancePolicies	10000000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5647000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	63000	usd
	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	4044000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27139000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	22768000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8178000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82972000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115459000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105740000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	8377000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	10557000	usd
	us-gaap	Interest Paid Net InterestPaidNet	26644000	usd
	us-gaap	Interest Paid Net InterestPaidNet	5890000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1369000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	21165000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	446000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	221715000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	30402000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	191313000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	235142000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25334000	usd
CY2022Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1506000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1433000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	3551000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	3155000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	216658000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	186725000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	221715000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	191313000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	56549000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2334000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	134764000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	28068000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	191313000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	30402000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	107667000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5373000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	95021000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	19961000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	202688000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	25334000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	86	loan
CY2023Q3	opbk	Debt Securities Issued By Government Sponsored Agencies Percentage DebtSecuritiesIssuedByGovernmentSponsoredAgenciesPercentage	0.97
CY2023Q3	opbk	Debt Securities Tax Exempt Municipal Securities Percentage DebtSecuritiesTaxExemptMunicipalSecuritiesPercentage	0.03
CY2023Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	3300000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	3300000	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-106000	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-145000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-106000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-438000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1759525000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	21617000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
CY2023Q3	us-gaap	Notes Receivable Net NotesReceivableNet	1737908000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1659051000	usd
CY2023Q3	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	314000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	160000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Credit Losses on Loans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company employs a modeled approach that takes into account current and future economic conditions to estimate lifetime expected losses on a collective basis. With the adoption of CECL, the Company elected not to consider </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accrued interest receivable in its estimated credit losses because the Company writes off uncollectible accrued interest receivable in a timely manner. The Company considers writing off accrued interest amounts once the amounts become 90 days past due to be considered within a timely manner. The Company has elected to write off accrued interest receivable by reversing interest income. The Company uses transition matrices to develop the Probability of Default ("PD") and Loss Given Default ("LGD") approach, incorporating quantitative factors and qualitative considerations in the calculation of the allowance for credit losses for collectively assessed loans. The model provides forecasts of PD and LGD based on national unemployment rates using regression analysis. The Company incorporates future economic conditions using a weighted multiple scenario approach: baseline and adverse. The Company applies a reasonable and supportable period of one year for the baseline scenario and two years for the adverse scenario, after which loss assumptions revert to historical loss information through a one-year reversion period for the baseline scenario and a two-year reversion period for the adverse scenario. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to quantify the credit risk impact of other trends and changes within the loan portfolio, the Company utilizes qualitative adjustments to the modeled estimated loss approaches. The parameters for making adjustments are established under a Credit Risk Matrix that provides different possible scenarios for each of the factors listed below. The Credit Risk Matrix and the possible scenarios enable the Bank to qualitatively adjust the loss rates. This matrix considers the following nine factors, which are patterned after the guidelines provided under the Federal Financial Institutions Examination Council Interagency Policy Statement on the Allowance for Credit Losses, updated to reflect the adoption of CECL:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in lending policies and procedures, including changes in underwriting standards and practices for collection, charge-offs, and recoveries;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Actual and expected changes in national and local economic and business conditions and developments in which the institution operates that affect the collectivity of loans;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the nature and volume of the loan portfolio;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the experience, ability, and depth of lending management and staff;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the volume and severity of past due loans, the volume of nonaccrual loans, and the volume and severity of adversely classified loans;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the quality of the credit review function; </span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the value of the underlying collateral for loans that are not collateral-dependent; </span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• The existence, growth, and effect of any concentrations of credit, and</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• The effect of other external factors, such as the regulatory, legal and technological environments; competition; and events such as natural disasters.</span></div>
CY2023Q3	opbk	Allowance For Credit Loss Reversion Period Baseline Scenario AllowanceForCreditLossReversionPeriodBaselineScenario	P1Y
CY2023Q3	opbk	Allowances For Credit Loss Reversion Period Adverse Scenario AllowancesForCreditLossReversionPeriodAdverseScenario	P2Y
CY2023Q3	opbk	Allowance For Credit Loss Reversion Period Baseline Scenario AllowanceForCreditLossReversionPeriodBaselineScenario	P1Y
CY2023Q3	opbk	Allowances For Credit Loss Reversion Period Adverse Scenario AllowancesForCreditLossReversionPeriodAdverseScenario	P2Y
	opbk	Financing Receivable Allowance For Credit Loss Number Of Matrix Factors FinancingReceivableAllowanceForCreditLossNumberOfMatrixFactors	9	factor
	opbk	Allowance For Credit Losses Non Accrual Loan AllowanceForCreditLossesNonAccrualLoan	250000	usd
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	250000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	20802000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1303000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	492000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	4000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	21617000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	17702000	usd
CY2022Q3	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	662000	usd
CY2022Q3	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2022Q3	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	5000	usd
CY2022Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	18369000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
	opbk	Financing Receivable Excluding Accrued Interest Credit Loss Impact Of Cecl Adoption FinancingReceivableExcludingAccruedInterestCreditLossImpactOfCECLAdoption	1924000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1045000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	628000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	35000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	21617000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	16123000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	2204000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	32000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	74000	usd
CY2022Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	18369000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	14000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	21603000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	21617000	usd
CY2023Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	3753000	usd
CY2023Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1755772000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1759525000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	279000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	18962000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
CY2022Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	702000	usd
CY2022Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1677590000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2023Q3	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	7100000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	702000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	423000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	279000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	279000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	810000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance	3401000	usd
CY2023Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	4211000	usd
CY2023Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	usd
CY2023Q3	opbk	Financing Receivable Excluding Accrued Interest Past Due FinancingReceivableExcludingAccruedInterestPastDue	4211000	usd
CY2022Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2639000	usd
CY2022Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	442000	usd
CY2022Q4	opbk	Financing Receivable Excluding Accrued Interest Past Due FinancingReceivableExcludingAccruedInterestPastDue	3081000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1759525000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2023Q3	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	7100000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2023Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	136000	usd
	us-gaap	Financing Receivable Modification To Total Financing Receivables Percent FinancingReceivableModificationToTotalFinancingReceivablesPercent	0.0093
CY2023Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	136000	usd
CY2023Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	136000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	185391000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	594654000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	293041000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	149791000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	186043000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	282013000	usd
CY2023Q3	opbk	Financing Receivable Excluding Accrued Interests Credit Loss Impact Of Cecl Adoption FinancingReceivableExcludingAccruedInterestsCreditLossImpactOfCECLAdoption	67404000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan	1188000	usd
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1759525000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	457000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	46000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	91000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff	34000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Revolving Writeoff FinancingReceivableExcludingAccruedInterestRevolvingWriteoff	0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan Writeoff FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoanWriteoff	0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	628000	usd
CY2023Q3	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	7100000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17222000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15269000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11844000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10869000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5378000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4400000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	308000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	349000	usd
	us-gaap	Depreciation Depreciation	975000	usd
	us-gaap	Depreciation Depreciation	1000000	usd
CY2023Q3	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	0	usd
CY2022Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	0	usd
CY2023Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12654000	usd
CY2022Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12341000	usd
CY2022Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12759000	usd
CY2021Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12720000	usd
CY2023Q3	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	1228000	usd
CY2022Q3	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	984000	usd
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	3302000	usd
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	3512000	usd
CY2023Q3	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	11931000	usd
CY2022Q3	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12889000	usd
CY2023Q3	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	11931000	usd
CY2022Q3	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12889000	usd
CY2023Q3	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	17000000	usd
CY2022Q3	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	17300000	usd
CY2023Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	420200000	usd
CY2022Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	356200000	usd
CY2023Q3	us-gaap	Time Deposit Maturities Remainder Of Fiscal Year TimeDepositMaturitiesRemainderOfFiscalYear	363264000	usd
CY2023Q3	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	465871000	usd
CY2023Q3	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	23893000	usd
CY2023Q3	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	17345000	usd
CY2023Q3	opbk	Time Deposit Maturities Year Four And Thereafter TimeDepositMaturitiesYearFourAndThereafter	420000	usd
CY2023Q3	us-gaap	Time Deposits TimeDeposits	870793000	usd
CY2023Q3	us-gaap	Deposit Liability Uninsured DepositLiabilityUninsured	1060000000.00	usd
CY2023Q3	opbk	Uninsured Deposit Liability Percent UninsuredDepositLiabilityPercent	0.582
CY2022Q4	us-gaap	Deposit Liability Uninsured DepositLiabilityUninsured	1140000000	usd
CY2022Q4	opbk	Uninsured Deposit Liability Percent UninsuredDepositLiabilityPercent	0.603
CY2023Q3	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	95000000	usd
CY2023Q3	us-gaap	Federal Home Loan Bank Advances Interest Rate FederalHomeLoanBankAdvancesInterestRate	0.0454
	opbk	Federal Home Loan Bank Advances Remaining Term FederalHomeLoanBankAdvancesRemainingTerm	P1Y2M12D
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	67000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	67000000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	662254000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1900000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7400000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10300000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.271
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.289
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.284
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.290
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	261968000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	270847000	usd
CY2023Q3	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	11128000	usd
CY2022Q4	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	12212000	usd
CY2023Q3	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	7185000	usd
CY2022Q4	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	8748000	usd
CY2023Q3	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	361000	usd
CY2022Q3	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	210000	usd
	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	1100000	usd
	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	584000	usd
CY2023Q3	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	456000	usd
CY2022Q3	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	418000	usd
	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	1400000	usd
	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	738000	usd
CY2023Q3	opbk	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	3	plan
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	323000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	335000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	961000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	858000	usd
CY2023Q3	opbk	Risk Weighted Assets Capital Conservation Buffer Percentage RiskWeightedAssetsCapitalConservationBufferPercentage	0.025
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	105740000	usd
CY2023Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1739499000	usd
CY2023Q3	opbk	Accrued Interest Receivable Fair Value Disclosure AccruedInterestReceivableFairValueDisclosure	7996000	usd
CY2023Q3	opbk	Time Deposits Placed Fair Value Disclosure TimeDepositsPlacedFairValueDisclosure	96000	usd
CY2023Q3	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	16978000	usd
CY2023Q3	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	1823429000	usd
CY2023Q3	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	94050000	usd
CY2023Q3	opbk	Accrued Interest Payable Fair Value Disclosure AccruedInterestPayableFairValueDisclosure	13552000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	82972000	usd
CY2022Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	47217000	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1626036000	usd
CY2022Q4	opbk	Accrued Interest Receivable Fair Value Disclosure AccruedInterestReceivableFairValueDisclosure	7180000	usd
CY2022Q4	opbk	Time Deposits Placed Fair Value Disclosure TimeDepositsPlacedFairValueDisclosure	95000	usd
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	16845000	usd
CY2022Q4	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	1880508000	usd
CY2022Q4	opbk	Accrued Interest Payable Fair Value Disclosure AccruedInterestPayableFairValueDisclosure	2771000	usd
CY2023Q3	us-gaap	Capital Capital	227275000	usd
CY2023Q3	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1331
CY2023Q3	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	206350000	usd
CY2023Q3	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1209
CY2023Q3	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	206350000	usd
CY2023Q3	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1209
CY2023Q3	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	206350000	usd
CY2023Q3	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.0963
CY2022Q4	us-gaap	Capital Capital	213862000	usd
CY2022Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1306
CY2022Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	194358000	usd
CY2022Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1187
CY2022Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	194358000	usd
CY2022Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1187
CY2022Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	194358000	usd
CY2022Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.0938
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	5121000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	8650000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18746000	usd
	us-gaap	Net Income Loss NetIncomeLoss	25282000	usd
CY2023Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	96000	usd
CY2022Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	188000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	379000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	532000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5025000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8462000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18367000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	24750000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15131587	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15195826	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15149203	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15158749	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5025000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8462000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	18367000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	24750000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15131587	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15195826	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15149203	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15158749	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8990	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	79330	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	51409	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	87596	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15140577	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15275156	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15200612	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15246345	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.62
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	opbk	Allowance For Credit Losses Non Accrual Loan AllowanceForCreditLossesNonAccrualLoan	250000	usd
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	250000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	21600000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19200000	usd
CY2023Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1400000	usd
CY2022Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	662000	usd

Files In Submission

Name	View Source	Status
0001628280-23-038620-index-headers.html	Edgar Link	pending
0001628280-23-038620-index.html	Edgar Link	pending
0001628280-23-038620.txt	Edgar Link	pending
0001628280-23-038620-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opbk-20230930.htm	Edgar Link	pending
opbk-20230930.xsd	Edgar Link	pending
opbk-20230930x10qexx311.htm	Edgar Link	pending
opbk-20230930x10qexx312.htm	Edgar Link	pending
opbk-20230930x10qexx321.htm	Edgar Link	pending
opbk-20230930x10qexx322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
opbk-20230930_pre.xml	Edgar Link	unprocessable
opbk-20230930_lab.xml	Edgar Link	unprocessable
opbk-20230930_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
opbk-20230930_cal.xml	Edgar Link	unprocessable
opbk-20230930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPBK
OP Bancorp Stock $opbk

2023 Q4 Form 10-Q Financial Statement

#000162828023038620 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPBK OP Bancorp Stock $opbk

2023 Q4 Form 10-Q Financial Statement

#000162828023038620 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPBK
OP Bancorp Stock $opbk